Similar articles

• A mutation in the human ryanodine receptor gene associated with central core disease.

  Zhang Y, Chen HS, Khanna VK, De Leon S, Phillips MS, Schappert K, Britt BA, Browell AK, MacLennan DH. Zhang Y, et al. Nat Genet. 1993 Sep;5(1):46-50. doi: 10.1038/ng0993-46. Nat Genet. 1993. PMID: 8220422
• Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia.

  Quane KA, Healy JM, Keating KE, Manning BM, Couch FJ, Palmucci LM, Doriguzzi C, Fagerlund TH, Berg K, Ording H, et al. Quane KA, et al. Nat Genet. 1993 Sep;5(1):51-5. doi: 10.1038/ng0993-51. Nat Genet. 1993. PMID: 8220423
• Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.

  Quane KA, Keating KE, Healy JM, Manning BM, Krivosic-Horber R, Krivosic I, Monnier N, Lunardi J, McCarthy TV. Quane KA, et al. Genomics. 1994 Sep 1;23(1):236-9. doi: 10.1006/geno.1994.1483. Genomics. 1994. PMID: 7829078
• Malignant hyperthermia and central core disease: disorders of Ca2+ release channels.

  Loke J, MacLennan DH. Loke J, et al. Am J Med. 1998 May;104(5):470-86. doi: 10.1016/s0002-9343(98)00108-9. Am J Med. 1998. PMID: 9626031 Review. No abstract available.
• [Molecular pathology of malignant hyperthermia and central core disease].

  Takagi A. Takagi A. Nihon Rinsho. 1997 Dec;55(12):3307-14. Nihon Rinsho. 1997. PMID: 9436456 Review. Japanese.